How To Use CPT Code 92587

CPT 92587 refers to the distortion product evoked otoacoustic emissions (DPOAE) test, a specialized diagnostic procedure used to evaluate hearing disorders, particularly in newborns and young children. This test is noninvasive and involves the measurement of sounds produced by the cochlea in response to auditory stimuli. By assessing the presence or absence of otoacoustic emissions, healthcare providers can determine the functionality of the cochlea and identify potential hearing impairments.

1. What is CPT code 92587?

CPT code 92587 represents a limited evaluation of distortion product evoked otoacoustic emissions or transient evoked otoacoustic emissions, including interpretation and report. This code is primarily utilized in the field of otorhinolaryngology, focusing on the assessment of hearing disorders. The procedure involves the use of an ear probe that emits specific sound frequencies into the ear canal, allowing for the detection of low-intensity sounds generated by the cochlea’s hair cells. The presence of these emissions indicates normal cochlear function, while their absence may suggest hearing impairment. This test is particularly valuable for screening purposes in infants and young children, as it provides a quick and effective means of assessing hearing capabilities without requiring subjective responses from the patient.

2. Qualifying Circumstances

The use of CPT code 92587 is appropriate under specific circumstances. It is intended for situations where a qualified healthcare provider, such as an audiologist, administers the test. The code should not be reported if the procedure is performed solely by a computer without professional oversight. This limitation is crucial, as automated tests may not provide the same level of diagnostic accuracy and interpretation as those conducted by trained professionals. Additionally, the tests must be conducted to confirm the presence or absence of a hearing disorder, focusing on three to six frequency levels. Inappropriate use of this code may occur if the tests are self-administered or if the results are generated without professional interpretation.

3. When To Use CPT 92587

CPT code 92587 is used when conducting a limited evaluation of otoacoustic emissions to assess hearing disorders. It is essential to ensure that the tests are administered by a qualified healthcare provider to maintain the integrity of the results. This code can be used in conjunction with other diagnostic codes when additional evaluations are necessary, but it should not be reported alongside codes for automated tests that do not involve professional administration. Providers must be cautious to avoid billing for services that do not meet the criteria outlined for this code, as doing so could lead to reimbursement issues.

4. Official Description of CPT 92587

Official Descriptor: Distortion product evoked otoacoustic emissions; limited evaluation (to confirm the presence or absence of hearing disorder, 3-6 frequencies) or transient evoked otoacoustic emissions, with interpretation and report.

5. Clinical Application

CPT code 92587 is applied in clinical settings to evaluate hearing function, particularly in populations at risk for hearing loss, such as newborns and young children. The procedure is essential for early detection of hearing impairments, which can significantly impact language development and overall quality of life. By identifying hearing disorders at an early stage, healthcare providers can implement timely interventions, such as hearing aids or other assistive devices, to support the patient’s auditory development. The noninvasive nature of the test makes it suitable for use in pediatric populations, allowing for quick assessments without causing discomfort.

5.1 Provider Responsibilities

The provider’s responsibilities during the procedure include preparing the necessary equipment, placing the ear probe tip into the patient’s ear canal, and ensuring that the environment is conducive to accurate testing. For the distortion product otoacoustic emission test, the provider emits pairs of tones at designated frequencies, while for the transient evoked otoacoustic emissions test, broad frequency range clicks or brief bursts of pure tone are used. The provider must monitor the test’s progress, interpret the findings, and prepare a comprehensive report detailing the results and any recommendations for further evaluation or intervention.

5.2 Unique Challenges

One of the unique challenges associated with the use of CPT code 92587 is ensuring that the tests are administered correctly and interpreted accurately. The reliance on technology can lead to potential misuse, particularly if automated systems are employed without professional oversight. Additionally, variations in patient cooperation, especially in young children, can affect the quality of the results. Providers must be adept at managing these challenges to ensure that the testing process yields reliable and valid outcomes.

5.3 Pre-Procedure Preparations

Before conducting the procedure, the provider must ensure that the patient is appropriately positioned and that the ear canal is clear of any obstructions. It may be necessary to conduct preliminary evaluations to assess the patient’s overall health and any factors that could influence hearing. The provider should also verify that the equipment is functioning correctly and calibrated for accurate measurements. Clear communication with the patient or guardians about the procedure can help alleviate any anxiety and improve cooperation during the test.

5.4 Post-Procedure Considerations

After the procedure, the provider must review the recorded data and interpret the findings to determine the presence or absence of hearing disorders. A detailed report should be generated, outlining the results and any recommendations for further evaluation or treatment. Follow-up appointments may be necessary to discuss the findings with the patient or guardians and to explore potential interventions if a hearing disorder is identified. Continuous monitoring and support may be required to ensure optimal auditory development in affected individuals.

6. Relevant Terminology

Otoacoustic Emissions (OAEs): Low-intensity sounds produced by the cochlea’s hair cells in response to auditory stimuli, indicating normal cochlear function.

Cochlea: A spiral-shaped organ in the inner ear responsible for converting sound vibrations into neural signals for the brain.

Distortion Product Otoacoustic Emissions (DPOAE): A specific type of OAE generated when the cochlea is stimulated by two different frequencies, resulting in the production of additional frequencies that can be measured.

Transient Evoked Otoacoustic Emissions (TEOAE): A type of OAE elicited by brief auditory stimuli, such as clicks or tone bursts, used to assess cochlear function.

Audiologist: A healthcare professional specializing in the assessment and treatment of hearing disorders.

7. Clinical Examples

1. A newborn is referred for a hearing screening after birth; the provider conducts the test to ensure normal cochlear function.

2. A pediatric patient presents with developmental delays; the provider uses the test to evaluate potential hearing impairments.

3. A child with a history of ear infections undergoes the procedure to assess any impact on hearing ability.

4. A school-aged child fails a routine hearing test; the provider performs the evaluation to confirm the presence of a hearing disorder.

5. An infant is screened for hearing loss as part of a state-mandated newborn screening program; the provider administers the test to ensure early detection.

6. A child with a family history of hearing loss is evaluated using the procedure to determine if they are at risk.

7. A patient with auditory processing issues undergoes the test to rule out peripheral hearing disorders.

8. A toddler is assessed for hearing capabilities before starting preschool; the provider conducts the evaluation to ensure readiness.

9. A child with speech delays is referred for testing; the provider uses the procedure to investigate possible hearing loss as a contributing factor.

10. A patient with a cochlear implant is monitored for device performance; the provider conducts the test to evaluate cochlear function.